ストックスクリーナーアプリを入手
1.76
5.88%
-0.11
アフターアワーズ：
1.79
0.03
+1.70%
前日終値:
$1.87
開ける：
$1.86
24時間の取引高:
2.95M
Relative Volume:
0.42
時価総額：
$211.45M
収益：
-
当期純損益:
$-225.14M
株価収益率:
-0.898
EPS:
-1.96
ネットキャッシュフロー:
$-192.27M
1週間 パフォーマンス:
-21.08%
1か月 パフォーマンス:
+60.00%
6か月 パフォーマンス:
+179.28%
1年 パフォーマンス:
+97.20%
1日の値動き範囲:
$1.75
$2.00
1週間の範囲:
$1.74
$2.34
52週間の値動き範囲:
$0.3546
$2.74
Invivyd Inc Stock (IVVD) Company Profile
IVVD を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
IVVD
Invivyd Inc
|
1.76 | 400.95M | 0 | -225.14M | -192.27M | -1.96 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Invivyd Inc Stock (IVVD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-06 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-04-05 | アップグレード | Guggenheim | Neutral → Buy |
| 2024-03-26 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-19 | アップグレード | Morgan Stanley | Underweight → Equal-Weight |
| 2023-05-01 | 開始されました | H.C. Wainwright | Buy |
Invivyd Inc (IVVD) 最新ニュース
How institutional buying supports Invivyd Inc. stockJuly 2025 Setups & Step-by-Step Trade Execution Guides - newser.com
Will Invivyd Inc. stock gain from strong economy2025 Trade Ideas & Fast Exit and Entry Trade Guides - newser.com
Invivyd Inc. stock momentum explainedLong Setup & Consistent Return Strategy Ideas - newser.com
Invivyd Inc. stock volume spike explained2025 AllTime Highs & Verified Chart Pattern Trade Signals - newser.com
Visual trend scoring systems applied to Invivyd Inc.2025 Institutional Moves & Weekly Breakout Watchlists - newser.com
Why analysts upgrade Invivyd Inc. stockJuly 2025 Analyst Calls & AI Enhanced Trading Signals - newser.com
Using economic indicators to assess Invivyd Inc. potentialJuly 2025 Sector Moves & AI Enhanced Trading Alerts - newser.com
What drives Invivyd Inc stock priceHead and Shoulders Patterns & Set Your Capital Stop-Loss Limits Effectively - earlytimes.in
Invivyd (NASDAQ:IVVD) Receives "Sell (E+)" Rating from Weiss Ratings - MarketBeat
Backtesting results for Invivyd Inc. trading strategiesWeekly Profit Recap & Accurate Intraday Trade Tips - newser.com
Invivyd, Inc. (NASDAQ:IVVD) Short Interest Up 156.9% in October - MarketBeat
Invivyd price target raised to $10 from $5 at H.C. Wainwright - MSN
HC Wainwright & Co. Maintains Invivyd (IVVD) Buy Recommendation - Nasdaq
H.C. Wainwright Maintains Invivyd(IVVD.US) With Buy Rating, Raises Target Price to $10 - 富途牛牛
Invivyd (IVVD) Analyst Rating: HC Wainwright Raises Price Target to $10 | IVVD Stock News - GuruFocus
Invivyd Highlights Antibody Development in New Presentation - MSN
Invivyd (IVVD) Price Target Increased by 88.89% to 5.78 - MSN
Why Invivyd Inc. stock is popular among millennialsTrade Volume Summary & Weekly High Momentum Picks - newser.com
Real time pattern detection on Invivyd Inc. stockWeekly Gains Summary & Growth Focused Stock Reports - newser.com
Candlestick signals on Invivyd Inc. stock todayOil Prices & High Yield Stock Recommendations - newser.com
Invivyd, Inc. (NASDAQ:IVVD) Given Average Rating of "Hold" by Brokerages - MarketBeat
[8-K] Invivyd, Inc. Reports Material Event | IVVD SEC FilingForm 8-K - Stock Titan
Invivyd, Inc. (IVVD) Discusses REVOLUTION Clinical Program and Development of VYD2311 Antibody for COVID PreventionSlideshow (NASDAQ:IVVD) 2025-10-30 - Seeking Alpha
Invivyd, Inc. (IVVD) Stock Price, News, Quote & History - Yahoo! Finance Canada
Using Python tools to backtest Invivyd Inc. strategiesJuly 2025 Closing Moves & High Accuracy Swing Entry Alerts - newser.com
Can Invivyd Inc. stock surprise with earnings upsideJuly 2025 Price Swings & AI Driven Price Forecasts - fcp.pa.gov.br
Invivyd to Host Webcast on the REVOLUTION Clinical Program for VYD2311, a Vaccine-Alternative Antibody to Prevent COVID - The Manila Times
Invivyd, Inc. to Host Webcast on REVOLUTION Clinical Program for VYD2311 Monoclonal Antibody Candidate Against COVID-19 - Quiver Quantitative
Invivyd (Nasdaq: IVVD) to host VYD2311 REVOLUTION webcast live at 8:30 a.m. ET - Stock Titan
Invivyd Inc (IVVD) 財務データ
収益
当期純利益
現金流量
EPS
1.62%
0.21%
大文字化:
|
ボリューム (24 時間):